newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Announces First Quarter 2024 Financial and Business Results

●Q1 Revenue of $10.3 million; a 4% increase year-over-year ●Q1 Test volume up 10% year over year to record levels PARSIPPANY, NJ, May 09, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. ("Interpace" or the